Oncolytic virus therapy is emerging as a low-cost, targeted cancer treatment. With over 60 trials in China, scientists see ...
Brain cancer, notorious for its aggressiveness and limited treatment options, may finally have a powerful ally.A patient at ...
Backed by a $2 million grant, University of New Mexico Comprehensive Cancer Center professor Eric Bartee's research raises ...
They say these low-cost, high-impact viruses are showing promise in clinical trials – there are around 60 currently under way ...
The University of New Mexico Comprehensive Cancer Center has received a $2 million grant to study a form of immune therapy ...
A new cancer therapy utilising a genetically modified herpes simplex virus type 1 (HSV-1) offers hope for late-stage patients ...
Candel Therapeutics has identified a subpopulation of lung cancer patients living longest on its oncolytic virus, leading the biotech to narrow its focus as it heads towards a potentially ...
Experimental therapy uses a modified virus to boost immunity and make anti-tumour treatments more effective, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results